Cargando…

Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease

Coronary artery disease (CAD) is the most common cause of heart failure with reduced ejection fraction (HFrEF). Advances and innovations in medical therapy have been shown to play a crucial role in improving the prognosis of patients with CAD and HFrEF; however, mortality rate in these patients rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acerbo, Vincenzo, Cesaro, Arturo, Scherillo, Gianmaria, Signore, Giovanni, Rotolo, Francesco Paolo, De Michele, Gianantonio, Scialla, Francesco, Raucci, Giuseppe, Panico, Domenico, Fimiani, Fabio, Moscarella, Elisabetta, Gragnano, Felice, Calabrò, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575800/ https://www.ncbi.nlm.nih.gov/pubmed/37493869 http://dx.doi.org/10.1007/s10741-023-10335-0

Ejemplares similares

Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options
por: Cesaro, Arturo, et al.
Publicado: (2023)

Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice
por: Cesaro, Arturo, et al.
Publicado: (2023)

Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?
por: Cesaro, Arturo, et al.
Publicado: (2022)

Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter()
por: Gragnano, Felice, et al.
Publicado: (2021)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Dietary Thiols: A Potential Supporting Strategy against Oxidative Stress in Heart Failure and Muscular Damage during Sports Activity
por: Brancaccio, Mariarita, et al.
Publicado: (2020)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy
por: Gragnano, Felice, et al.
Publicado: (2017)

Methicillin-Resistant Staphylococcus aureus: Risk for General Infection and Endocarditis Among Athletes
por: Brancaccio, Mariarita, et al.
Publicado: (2020)

Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination
por: Scudiero, Olga, et al.
Publicado: (2021)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Clinical Insights to Complete and Incomplete Surgical Revascularization in Atrial Fibrillation and Multivessel Coronary Disease
por: Pasierski, Michal, et al.
Publicado: (2022)

Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis
por: Hu, Meng-Jin, et al.
Publicado: (2021)

Case Report: Key Role of the Impella Device to Achieve Complete Revascularization in a Patient With Complex Multivessel Disease and Severely Depressed Left Ventricular Function
por: Monizzi, Giovanni, et al.
Publicado: (2021)

Trends in Guideline-Driven Revascularization in Diabetic Patients with Multivessel Coronary Heart Disease
por: Rumana, Umme, et al.
Publicado: (2019)

Total versus staged versus functional revascularization in NSTEACS patients with multivessel disease
por: Elkady, Ahmed O., et al.
Publicado: (2021)

Complete revascularization with PCI in STEMI patients with multivessel disease, when is the appropriate time?
por: Aquino-Bruno, Heberto, et al.
Publicado: (2023)

Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease
por: Park, Hyukjin, et al.
Publicado: (2015)

Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions
por: Rezende, Paulo Cury, et al.
Publicado: (2017)

Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021)

Zero-Contrast Multivessel Revascularization for Acute Coronary Syndrome in a Patient With Chronic Kidney Disease
por: Madhavan, Mahesh V., et al.
Publicado: (2019)

Revascularization strategies in patients with multivessel coronary artery disease: a Bayesian network meta-analysis
por: Van den Eynde, Jef, et al.
Publicado: (2021)

Controversies in cardiac surgery: do multivessel arterial revascularization and beating heart bypass operations improve prognosis?
por: Bargagna, Marta, et al.
Publicado: (2019)

Comparison of SYNTAX and Gensini Scores in the Decision of Surgery or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease
por: Boyraz, Bedrettin, et al.
Publicado: (2022)

Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry
por: Bruno, Francesco, et al.
Publicado: (2023)

Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Loutfi, Mohamed, et al.
Publicado: (2016)

Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta‐Analysis
por: Nagaraja, Vinayak, et al.
Publicado: (2016)

Corrigendum to: Controversies in cardiac surgery: do multivessel arterial revascularization and beating heart bypass operations improve prognosis?
Publicado: (2019)

Angiographic Complete versus Clinical Selective Incomplete Percutaneous Revascularization in Heart Failure Patients with Multivessel Coronary Disease
por: Chang, Chieh-Yu, et al.
Publicado: (2020)

Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e‐Ultimaster registry
por: Williams, Timothy, et al.
Publicado: (2021)

Establishment of a Predictive Model for Poor Prognosis of Incomplete Revascularization in Patients with Coronary Heart Disease and Multivessel Disease
por: Lian, Huan, et al.
Publicado: (2022)

Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice
por: Chung, Woo-Young, et al.
Publicado: (2016)

Optimal Revascularization Strategy in Non–ST‐Segment–Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit‐Only Versus One‐Stage Versus Multistage Revascularization
por: Kim, Min Chul, et al.
Publicado: (2020)

Acute coronary syndromes and multivessel coronary artery disease
por: Zimbardo, Giuseppe, et al.
Publicado: (2023)

Additional right-sided upper “Half-Mini-Thoracotomy” for aortocoronary bypass grafting during minimally invasive multivessel revascularization
por: Aubin, Hug, et al.
Publicado: (2015)

Revascularization for Left Main and Multivessel Coronary Artery Disease: Current Status and Future Prospects after the EXCEL and NOBLE Trials
por: Al-Hijji, Mohammed, et al.
Publicado: (2018)

Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is FFR-Guided Strategy Still Valuable?
por: Shin, Doosup, et al.
Publicado: (2022)

Defining the optimal approach to revascularization in chronic coronary syndrome patients with diabetes and multivessel disease: Is our equipoise evidence-based?
por: Ostrominski, John W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3sda7ocq05hv7j2fel226uk0j4